Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its ...

Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall response rate compared to chemotherapy. Trastuzumab deruxtecan plus pertuzumab ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Discover how Pitavastatin, a cholesterol-lowering drug, shows promise as a treatment for triple-negative breast cancer.

For Chase Johnson, an unexpected change in her dog’s behavior became a life-altering warning. At 31, Johnson noticed her ...

Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with ...

New research shows that women living near Superfund sites are more likely to develop aggressive and metastatic breast cancers ...

Although it is commonly known that breast cancer is classified into different stages, many may be unaware that there are also different types of breast cancer. One rare form of the disease is ...